Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |